XML 43 R4.htm IDEA: XBRL DOCUMENT v2.4.1.9
Condensed Consolidated Statements of Income (Unaudited) (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended
Mar. 31, 2015
Mar. 31, 2014
Net sales $ 472,821us-gaap_SalesRevenueNet $ 509,344us-gaap_SalesRevenueNet
Cost of goods sold 202,715us-gaap_CostOfGoodsSold 234,055us-gaap_CostOfGoodsSold
Gross profit 270,106us-gaap_GrossProfit 275,289us-gaap_GrossProfit
Selling, general and administrative expense 188,555us-gaap_SellingGeneralAndAdministrativeExpense 202,275us-gaap_SellingGeneralAndAdministrativeExpense
Research and Development Expense 47,202us-gaap_ResearchAndDevelopmentExpense 52,543us-gaap_ResearchAndDevelopmentExpense
Segment profit (loss) 34,349us-gaap_OperatingIncomeLoss 20,471us-gaap_OperatingIncomeLoss
Interest expense 5,002us-gaap_InterestExpense 3,857us-gaap_InterestExpense
Foreign exchange losses, net 3,806us-gaap_ForeignCurrencyTransactionGainLossBeforeTax 2,737us-gaap_ForeignCurrencyTransactionGainLossBeforeTax
Other (income) expense, net (1,153)us-gaap_OtherNonoperatingIncomeExpense (661)us-gaap_OtherNonoperatingIncomeExpense
Income before income taxes 26,694us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments 14,538us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Provision for income taxes (8,876)us-gaap_IncomeTaxExpenseBenefit (7,870)us-gaap_IncomeTaxExpenseBenefit
Net income including noncontrolling interests 17,818us-gaap_ProfitLoss 6,668us-gaap_ProfitLoss
Net income attributable to Bio-Rad $ 17,818us-gaap_NetIncomeLoss $ 6,668us-gaap_NetIncomeLoss
Basic earnings per share:    
Net income per share basic attributable to Bio-Rad $ 0.61us-gaap_EarningsPerShareBasic $ 0.23us-gaap_EarningsPerShareBasic
Weighted average common shares - basic 29,092us-gaap_WeightedAverageNumberOfSharesOutstandingBasic 28,791us-gaap_WeightedAverageNumberOfSharesOutstandingBasic
Diluted earnings per share:    
Net income per share diluted attributable to Bio-Rad $ 0.61us-gaap_EarningsPerShareDiluted $ 0.23us-gaap_EarningsPerShareDiluted
Weighted average common shares - diluted 29,289us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding 29,059us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding